Susceptibility testing of Mycobacterium avium complex isolates
- 1 August 1996
- journal article
- review article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 40 (8) , 1759-1767
- https://doi.org/10.1128/aac.40.8.1759
Abstract
No abstract availableThis publication has 95 references indexed in Scilit:
- Treatment of Mycobacterium avium Complex Infection: Do the Results of In Vitro Susceptibility Tests Predict Therapeutic Outcome in Humans?The Journal of Infectious Diseases, 1996
- Recommendations on Prophylaxis and Therapy for Disseminated Mycobacterium avium Complex Disease in Patients Infected with the Human Immunodeficiency VirusNew England Journal of Medicine, 1993
- Effectiveness of the macrolide clarithromycin in the treatment ofMycobacterium avium complex infection in HIV-infected patientsInfection, 1992
- Incidence of Mycobacterium avium-intracellulare Complex Bacteremia in Human Immunodeficiency Virus-Positive PatientsThe Journal of Infectious Diseases, 1992
- Mycobacterium aviumComplex and the Normal HostsNew England Journal of Medicine, 1989
- Infection withMycobacterium aviumComplex in Patients without Predisposing ConditionsNew England Journal of Medicine, 1989
- Bacteriostatic and bactericidal activity of ciprofloxacin and ofloxacin against mycobacterium tuberculosis and mycobacterium avium complexTubercle, 1987
- Comparative in vitro activities of ampicillin, BMY 28142, and imipenem against Mycobacterium avium complexDiagnostic Microbiology and Infectious Disease, 1987
- Amikacin, ethambutol, and rifampin for treatment of disseminated Mycobacterium avium-intracellulare infections in patients with acquired immune deficiency syndromeDiagnostic Microbiology and Infectious Disease, 1986
- Surgical treatment of atypical mycobacterial lymphadenitis in childrenThe Pediatric Infectious Disease Journal, 1985